| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |